All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • LB-100Phase 21 trial

    Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes

  • LBL-033Phase 21 trial

    Nanjing Leads Biolabs Co.,Ltd · Advanced Malignant Tumors

  • LBL-034Phase 21 trial

    Nanjing Leads Biolabs Co.,Ltd · Relapsed/Refractory Multiple Myeloma

  • LBS-007Phase 21 trial

    Lin BioScience, Inc · Relapsed or Resistant Acute Leukaemias

  • LCB02APhase 21 trial

    LigaChem Biosciences, Inc. · Advanced Solid Tumors

  • LCB84Phase 21 trial

    LigaChem Biosciences, Inc. · Advanced Solid Tumors

  • LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial

    LEO Pharma · Atopic Dermatitis

  • leronlimabPRO 140Phase 21 trial

    CytoDyn, Inc. · Metastatic Colorectal Cancer (mCRC)

  • LesigerceptPhase 21 trial

    Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)

  • Letetresgene autoleucellete-cel, GSK3377794Phase 21 trial

    USWM CT, LLC · Neoplasms

  • LEU011Phase 21 trial

    Leucid Bio · Tumor, Solid

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LHP588Phase 21 trial

    Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

  • LIB-01Phase 21 trial

    Dicot AB · Erectile Dysfunction

  • Jiangsu HengRui Medicine Co., Ltd. · Relapsed/Refractory Indolent NHL

  • LinrodostatBMS-986205Phase 21 trial

    Bristol Myers Squibb · Advanced Cancer

  • linvemastatFP-020Phase 21 trial

    Foresee Pharmaceuticals Co., Ltd. · Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma

  • LipovirtidePhase 21 trial

    Shanxi Kangbao Biological Product Co., Ltd. · HIV

  • Liso-celPhase 21 trial

    Bristol Myers Squibb · Lymphoma

  • LLX-424Phase 21 trial

    Lilac Therapeutics, Inc. · Kidney Stones

  • LM-2417Phase 21 trial

    LaNova Medicines Limited · Advanced Solid Tumor

  • LM-350Phase 21 trial

    LaNova Medicines Limited · Malignant Tumors

  • LM101Phase 21 trial

    LaNova Medicines Limited · Malignant Tumors

  • LNP1265Phase 21 trial

    Regeneron · Hemophilia B

  • lonigutamabPhase 21 trial

    ACELYRIN Inc. · Thyroid Eye Disease

  • LP-184Phase 21 trial

    Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM

  • LP-98Phase 21 trial

    Shanxi Kangbao Biological Product Co., Ltd. · HIV

  • LPM6690176Phase 21 trial

    Luye Pharma Group Ltd. · Metastatic Colorectal Cancer (mCRC)

  • LQ036Phase 21 trial

    Shanghai Novamab Biopharmaceuticals Co., Ltd. · Asthma

  • LSALT PeptideMetablokPhase 21 trial

    Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery

  • LSAM-CisplatinPhase 21 trial

    NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) · Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG), Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma

  • LTG-001Phase 21 trial

    Latigo Biotherapeutics · Acute Pain, Postoperative

  • LTI-03Phase 21 trial

    Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)

  • LTT462Phase 21 trial

    Novartis · Melanoma

  • LTX-002Phase 21 trial

    Leal Therapeutics, Inc · Amyotrophic Lateral Sclerosis

  • Lu-177-DGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • lufepirsenNEXAGONPhase 21 trial

    Glaukos Corporation · Persistent Corneal Epithelial Defect

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • LV232Phase 21 trial

    Vigonvita Life Sciences · MDD

  • LW231Phase 21 trial

    Shanghai Longwood Biopharmaceuticals Co., Ltd. · Chronic HBV Infection

  • LXE408Phase 21 trial

    Novartis · Chagas Disease

  • LY01021Phase 21 trial

    Luye Pharma Group Ltd. · Assisted Reproduction

  • LY03015LPM3770164 sustained releasePhase 21 trial

    Luye Pharma Group Ltd. · Tardive Dyskinesia (TD)

  • LY03020Phase 21 trial

    Luye Pharma Group Ltd. · Schizophrenia

  • LY2784544Phase 21 trial

    Eli Lilly · Neoplasms, Hematologic

  • LY3457263Phase 21 trial

    Eli Lilly · Type 2 Diabetes

  • LY3537021Phase 21 trial

    Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions

  • LY3848575Phase 21 trial

    Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy

  • LY3871801Phase 21 trial

    Eli Lilly · Rheumatoid Arthritis

  • LY3884961Phase 21 trial

    Prevail Therapeutics · Parkinson Disease

NewerPage 60 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.